This device is FDA-cleared for US sales, US patent pending, and medically certified in Europe. It treats oncologic and neuropathic pain through a biophysical rather than biochemical approach. The non-invasive device is designed to create self-like neurons by applying surface electrodes to the skin to simultaneously treat multiple pain areas.

This patented technology is a flowable, moldable paste that can conform to and interdigitate with the host bone. It’s superior compressive strength, due to use of nano-particle technology, allows this Bone Biomaterial to be used for both weight and non-weight bearing bones. It rapidly hardens within the body and in the presence of serum, forming a solid bone-like structure capable of stabilizing fractured bone within five to 15 minutes. Bone Biomaterial is also useful as a bone substitute, eliminating the need for autologous or allogenic bone grafts. Because it is moldable, it may be used to manufacture orthopedic hardware such as intermedullary nails, screws and plates that later are absorbed by the body. This technology has broader applications than currently marketed products, with potential opportunities in medical devices, biotechnology, and tissue engineering, as well as veterinary and dental uses.